Morgan Adam

CIK 0001964335

Director10% Owner

Filings

Latest Feb 3, 2026

Issuers covered

Showing

13 of 13

Page 1

Track record

3 of 4 open-market trades scored (75% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	3	67%	+25.5%	+25.4%	+52.8%	-1.5%
90 days	3	33%	-16.1%	-16.7%	+22.1%	-53.6%
180 days	3	33%	+18.4%	0.0%	+59.4%	-4.3%
365 days	2	50%	+33.6%	+33.6%	+131.9%	-64.6%

Issuers

Companies where Morgan Adam has filed

Ticker	Issuer	Filings	Last filed
HRTX	Heron Therapeutics, Inc. /De/	7	Feb 3, 2026
ALIM	Alimera Sciences Inc	5	Sep 16, 2024
JSPR	Jasper Therapeutics, Inc.	1	Feb 9, 2024

All filings

13 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Feb 3, 2026	HRTXHeron Therapeutics, Inc. /De/	AGrant	53,960	$0.00	$0
Aug 12, 2025	HRTXHeron Therapeutics, Inc. /De/	PPurchase	1,766,546	$1.50	$2,649,819
Feb 4, 2025	HRTXHeron Therapeutics, Inc. /De/A	AGrant	17,950	$0.00	$0
Feb 3, 2025	HRTXHeron Therapeutics, Inc. /De/	AGrant	17,950	$0.00	$0
Sep 16, 2024	ALIMAlimera Sciences Inc	DDisposition	9,429,808	-	-
Feb 9, 2024	JSPRJasper Therapeutics, Inc.	PPurchase	350,000	$12.95	$4,532,500
Jan 19, 2024	HRTXHeron Therapeutics, Inc. /De/	AGrant	13,948	$0.00	$0
Oct 4, 2023	ALIMAlimera Sciences Inc	Holdings only	-	-	-
Aug 17, 2023	ALIMAlimera Sciences Inc	CConversion	4,845,392	$1.70	$8,237,166
Jul 25, 2023	HRTXHeron Therapeutics, Inc. /De/	PPurchase	2,486,744	$1.37	$3,406,839
May 19, 2023	ALIMAlimera Sciences Inc	PPurchase	1,401,901	$1.70	$2,383,232
Mar 28, 2023	ALIMAlimera Sciences Inc	Holdings only	-	-	-
Feb 24, 2023	HRTXHeron Therapeutics, Inc. /De/	AGrant	37,879	$0.00	$0

Showing 1-13 of 13

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value